Imcd N.v. · EURONEXT:IMCD
Imcd — 9M 2020 Earnings Presentation
16 slides from Imcd's earnings presentation, Nov 11, 2020
Slide 1: Conference Call: First nine months 2020 results
Page CONFERENCE CALL First nine months 2020 results IMCD N.V. 11 November 2020
Slide 2: Disclaimer
Page 2 Disclaimer This presentation may contain forward looking statements. These statements are based on current expectations, estimates and projections of IMCD’s management and information currently available to the company. IMCD cautions that such statements contain elements of risk and uncertain
Slide 3: Presenting team
Page 3 Presenting team Piet van der Slikke, CEO Hans Kooijmans, CFO Led the formation of IMCD since 1995 Joined IMCD in 1996 Designed and executed IMCD’s strategy Co-led formation of IMCD 25 years of industry experience 24 years of industry experience
Slide 4: Agenda
Page 4 Agenda • Company profile • Highlights first nine months 2020 • Financials first nine months 2020 • Outlook • Q&A
Slide 5: Company profile
Page 5 Company profile IMCD is a market-leader in the sales, marketing and distribution of speciality chemicals and food ingredients. Its result-driven professionals provide market-focused solutions to suppliers and customers across EMEA, Asia-Pacific and Americas, offering a range of comprehensive
Slide 6: Agenda
Page 6 Agenda • Company profile • Highlights first nine months 2020 • Financials first nine months 2020 • Outlook • Q&A
Slide 7: Highlights first nine months 2020
Page 7 Highlights first nine months 2020 GROSS PROFIT • Gross profit growth of 6% to EUR 486 million (+9% on a constant currency basis) OPERATING EBITA • Operating EBITA increase of 8% to EUR 190 million (+11% on a constant currency basis) NET RESULT • Net result before amortisation and non-recurrin
Slide 8: Highlights first nine months 2020: M&A and financing
Page 8 Highlights first nine months 2020 M&A Q3 2020 • Acquisition of the pharmaceutical business of Develing International Trade (Shanghai) Co. Ltd in July • Strengthening of Brazilian Food & Nutrition business with the acquisition of VitaQualy in August • Acquisition of 70% of the outstanding shar
Slide 9: Agenda
Page 9 Agenda • Company profile • Highlights first nine months 2020 • Financials first nine months 2020 • Outlook • Q&A
Slide 10: Financials first nine months 2020: Key figures
Page 10 Financials first nine months 2020 Key figures Jan. 1 - Sept. 30 Jan. 1 - Sept. 30 Fx adj. EUR millio n 2020 2019 Change Change Change Revenue 2,082 2,061 21 1% 3% Gross profit 486 457 28 6% 9% Gross profit in % of revenue 23.3% 22.2% 1.1% Operating EBITA 190 176 14 8% 11% Operating EBITA in
Slide 11: Financials first nine months 2020: Income statement
Page 11 Financials first nine months 2020 Income statement Asia Holding EMEA Americas Total EUR million Pacific companies Gross profit YTD Q3 2020 256 159 71 486 YTD Q3 2019 250 148 59 457 ∆ reported 2% 7% 21% 6% ∆ constant currency 4% 11% 25% 9% Operating EBITA YTD Q3 2020 100 70 32 (12) 190 YTD Q3
Slide 12: Financials first nine months 2020: Free cash flow
Page 12 Financials first nine months 2020 Free cash flow Jan.1 - Sept 30 Jan.1 - Sept 30 EUR million change change 2020 2019 Operating EBITA 190 176 14 8% Depreciation 18 16 2 Operating EBITDA 208 192 17 9% Share based payments 3 2 1 IAS 17 lease payments (19) (16) (4) Adjusted operating EBITDA 192
Slide 13: Financials first nine months 2020: Net debt/leverage
Page 13 Financials first nine months 2020 30 September 31 December 30 September Net debt/leverage 2020 2019 2019 Reported Net Debt 319 735 672 (incl. new share capital/ IFRS 16 debt) Reported leverage ratio: Reported (incl. full year impact of acquisitions) 1.2 2.8 2.8 Pro forma excluding proceeds n
Slide 14: Agenda
Page 14 Agenda • Company profile • Highlights first nine months 2020 • Financials first nine months 2020 • Outlook • Q&A
Slide 15: Outlook
Page 15 Outlook IMCD operates in different, often fragmented market segments in multiple geographic regions, connecting many customers and suppliers across a very diverse product range. In general, results are impacted by macroeconomic conditions and developments in specific industries. Furthermore,
Slide 16: Agenda: Q&A
Page 16 Agenda • Company profile • Highlights first nine months 2020 • Financials first nine months 2020 • Outlook • Q&A